Ustell is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Biocomp Pharma, Inc.. The primary component is Methenamine; Sodium Phosphate, Monobasic, Monohydrate; Phenyl Salicylate; Methylene Blue; Hyoscyamine Sulfate.
| Product ID | 44523-743_8140e229-8ab3-31ba-e053-2a91aa0a5b3d |
| NDC | 44523-743 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ustell |
| Generic Name | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-02-11 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | BioComp Pharma, Inc. |
| Substance Name | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| Active Ingredient Strength | 120 mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-02-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-02-11 |
| Ingredient | Strength |
|---|---|
| METHENAMINE | 120 mg/1 |
| SPL SET ID: | 813f4747-7cea-a68d-e053-2991aa0a93de |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0076-0903 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 44523-743 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0076-0902 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 44523-742 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0076-0111 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0178-0740 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0682-0334 | Urimar-T | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 79043-334 | Urimar-T | methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate |
| 54859-701 | Urin | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 79043-450 | URO-SP | Methenamine, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, and HYOSCYAMINE SULFATE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() USTELL 85534464 4168124 Live/Registered |
BIOCOMP PHARMA, INC. 2012-02-06 |